Internal Medicine, Hematology & Oncology · Houston, TX
NPI
1356508501
Since 2008
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
13310 Beamer Rd Ste B
Houston, TX, 77089
Phone (832) 879-2942
Groups this clinician bills Medicare through
Medicare paid, 2024
$139K
3,218 services
Medicare patients, 2024
255
Average age 75
Drug cost, 2024
$678K
1,600 prescriptions
Company payments, 2025
$1,167
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Irfan Jawed was code J2916 (injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg), 635 times for 22 patients. In total Irfan Jawed billed 3,218 services in 32 codes, and Medicare paid $139K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-08-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2916 Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg | Office | 635 | 22 | $1.75 | $1,113 |
| 99233 Hospital E&M - Subsequent | Facility | 598 | 165 | $85.45 | $51K |
| 99232 Hospital E&M - Subsequent | Facility | 227 | 99 | $57.02 | $13K |
| 99223 Hospital E&M - Initial | Facility | 181 | 158 | $124.11 | $22K |
| 99497 Care Management/Coordination | Facility | 154 | 138 | $54.56 | $8,402 |
| 99498 Care Management/Coordination | Facility | 152 | 137 | $51.44 | $7,820 |
| 99214 Office E&M - Established | Office | 138 | 73 | $87.96 | $12K |
| 99213 Office E&M - Established | Office | 111 | 58 | $63.02 | $6,996 |
| J7050 Infusion, normal saline solution, 250 cc | Office | 99 | 28 | $0.51 | $50.16 |
| 96367 Intravenous Infusion, Hydration | Office | 79 | 29 | $19.25 | $1,520 |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 72 | 28 | $0.62 | $44.6 |
| 96365 Intravenous Infusion, Hydration | Office | 69 | 25 | $45.06 | $3,109 |
| 96366 Intravenous Infusion, Hydration | Office | 63 | 24 | $14.62 | $921 |
| 99205 Office E&M - New | Office | 11 | 11 | $161.55 | $1,777 |
By year: 2022 $518K for 28,004 services; 2023 $272K for 9,522 services; 2024 $139K for 3,218 services.
Medicare prescription drug claims, 2024
In 2024, the drug Irfan Jawed prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 443 prescriptions and refills. In total Irfan Jawed wrote 1,600 Medicare prescriptions that cost $678K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 443 | 443 | 73 | $8,570 |
| Oxycodone Hcl Generic | 122 | 122 | 22 | $1,885 |
| Gabapentin Generic | 121 | 127 | 20 | $1,083 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 102 | 102 | 17 | $2,454 |
| Tizanidine Hcl Generic | 81 | 89 | Under 11 | $1,127 |
| Eliquis Apixaban | 76 | 106 | 30 | $62K |
| Sps Sodium Polystyrene Sulfon/Sorb | 52 | 52 | 41 | $4,923 |
| Carisoprodol Generic | 51 | 51 | Under 11 | $830 |
| Cyclobenzaprine Hcl Generic | 46 | 46 | Under 11 | $483 |
| Morphine Sulfate Er Morphine Sulfate | 42 | 42 | Under 11 | $2,106 |
| Keytruda Pembrolizumab | 37 | 37 | Under 11 | $435K |
| Warfarin Sodium Generic | 30 | 57 | Under 11 | $170 |
| Xarelto Rivaroxaban | 28 | 38 | Under 11 | $22K |
| Lidocaine Generic | 26 | 26 | Under 11 | $1,453 |
| Tramadol Hcl Er Tramadol Hcl | 26 | 26 | Under 11 | $900 |
Brand drugs: 190 claims; generic drugs: 1,410 claims; opioid claims: 785.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Irfan Jawed $1,167 ($1,167 in general payments such as food, travel and fees) from 21 companies. The largest payer was Alexion Pharmaceuticals, Inc. with $196.
| Company | Payments | Amount |
|---|---|---|
| Alexion Pharmaceuticals, Inc. AZN | 2 | $196 |
| Eisai Inc. 4523.T | 4 | $120 |
| E.R. Squibb & Sons, L.L.C. BMY | 5 | $106 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $95.15 |
| Daiichi Sankyo Inc. 4568.T | 3 | $80.43 |
| Sobi, Inc SOBI.ST | 2 | $71.79 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $60.96 |
| PharmaEssentia USA Corporation 6446.TW | 2 | $46.06 |
| Genzyme Corporation SNY | 1 | $39.91 |
| TerSera Therapeutics LLC | 1 | $37.71 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.